Cargando…

Assessment of surfactant use in preterm infants as a marker of neonatal intensive care unit quality

BACKGROUND: Proposed neonatal quality measures have included structural measures such as average daily census, and outcome measures such as mortality and rates of complications of prematurity. However, process measures have remained largely unexamined. The objective of this research was to examine v...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaplan, Heather C, Lorch, Scott A, Pinto-Martin, Jennifer, Putt, Mary, Silber, Jeffrey H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045285/
https://www.ncbi.nlm.nih.gov/pubmed/21281485
http://dx.doi.org/10.1186/1472-6963-11-22
_version_ 1782198802371837952
author Kaplan, Heather C
Lorch, Scott A
Pinto-Martin, Jennifer
Putt, Mary
Silber, Jeffrey H
author_facet Kaplan, Heather C
Lorch, Scott A
Pinto-Martin, Jennifer
Putt, Mary
Silber, Jeffrey H
author_sort Kaplan, Heather C
collection PubMed
description BACKGROUND: Proposed neonatal quality measures have included structural measures such as average daily census, and outcome measures such as mortality and rates of complications of prematurity. However, process measures have remained largely unexamined. The objective of this research was to examine variation in surfactant use as a possible process measure of neonatal quality. METHODS: We obtained data on infants 30 to 34 weeks gestation admitted with respiratory distress syndrome (RDS) within 48 hours of birth to 16 hospitals participating in the Pediatric Health Information Systems database from 2001-2006. Models were developed to describe hospital variation in surfactant use and identify patient and hospital predictors of use. Another cohort of all infants admitted within 24 hours of birth was used to obtain adjusted neonatal intensive care unit (NICU) mortality rates. To assess the construct validity of surfactant use as a quality metric, adjusted hospital rates of mortality and surfactant use were compared using Kendall's tau. RESULTS: Of 3,633 infants, 46% received surfactant. For individual hospitals, the adjusted odds of surfactant use varied from 2.2 times greater to 5.9 times less than the hospital with the median adjusted odds of surfactant use. Increased annual admissions of extremely low birth weight infants to the NICU were associated with greater surfactant use (OR 1.80, 95% CI 1.02-3.19). The correlation between adjusted hospital rates of surfactant use and in-hospital mortality was 0.37 (Kendall's tau p = 0.051). CONCLUSIONS: Though results were encouraging, efforts to examine surfactant use in infants with RDS as a process measure reflecting quality of care revealed significant challenges. Difficulties related to adequate measurement including defining RDS using administrative data, accounting for care received prior to transfer, and adjusting for severity of illness will need to be addressed to improve the utility of this measure.
format Text
id pubmed-3045285
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30452852011-02-26 Assessment of surfactant use in preterm infants as a marker of neonatal intensive care unit quality Kaplan, Heather C Lorch, Scott A Pinto-Martin, Jennifer Putt, Mary Silber, Jeffrey H BMC Health Serv Res Research Article BACKGROUND: Proposed neonatal quality measures have included structural measures such as average daily census, and outcome measures such as mortality and rates of complications of prematurity. However, process measures have remained largely unexamined. The objective of this research was to examine variation in surfactant use as a possible process measure of neonatal quality. METHODS: We obtained data on infants 30 to 34 weeks gestation admitted with respiratory distress syndrome (RDS) within 48 hours of birth to 16 hospitals participating in the Pediatric Health Information Systems database from 2001-2006. Models were developed to describe hospital variation in surfactant use and identify patient and hospital predictors of use. Another cohort of all infants admitted within 24 hours of birth was used to obtain adjusted neonatal intensive care unit (NICU) mortality rates. To assess the construct validity of surfactant use as a quality metric, adjusted hospital rates of mortality and surfactant use were compared using Kendall's tau. RESULTS: Of 3,633 infants, 46% received surfactant. For individual hospitals, the adjusted odds of surfactant use varied from 2.2 times greater to 5.9 times less than the hospital with the median adjusted odds of surfactant use. Increased annual admissions of extremely low birth weight infants to the NICU were associated with greater surfactant use (OR 1.80, 95% CI 1.02-3.19). The correlation between adjusted hospital rates of surfactant use and in-hospital mortality was 0.37 (Kendall's tau p = 0.051). CONCLUSIONS: Though results were encouraging, efforts to examine surfactant use in infants with RDS as a process measure reflecting quality of care revealed significant challenges. Difficulties related to adequate measurement including defining RDS using administrative data, accounting for care received prior to transfer, and adjusting for severity of illness will need to be addressed to improve the utility of this measure. BioMed Central 2011-01-31 /pmc/articles/PMC3045285/ /pubmed/21281485 http://dx.doi.org/10.1186/1472-6963-11-22 Text en Copyright ©2011 Kaplan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kaplan, Heather C
Lorch, Scott A
Pinto-Martin, Jennifer
Putt, Mary
Silber, Jeffrey H
Assessment of surfactant use in preterm infants as a marker of neonatal intensive care unit quality
title Assessment of surfactant use in preterm infants as a marker of neonatal intensive care unit quality
title_full Assessment of surfactant use in preterm infants as a marker of neonatal intensive care unit quality
title_fullStr Assessment of surfactant use in preterm infants as a marker of neonatal intensive care unit quality
title_full_unstemmed Assessment of surfactant use in preterm infants as a marker of neonatal intensive care unit quality
title_short Assessment of surfactant use in preterm infants as a marker of neonatal intensive care unit quality
title_sort assessment of surfactant use in preterm infants as a marker of neonatal intensive care unit quality
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045285/
https://www.ncbi.nlm.nih.gov/pubmed/21281485
http://dx.doi.org/10.1186/1472-6963-11-22
work_keys_str_mv AT kaplanheatherc assessmentofsurfactantuseinpreterminfantsasamarkerofneonatalintensivecareunitquality
AT lorchscotta assessmentofsurfactantuseinpreterminfantsasamarkerofneonatalintensivecareunitquality
AT pintomartinjennifer assessmentofsurfactantuseinpreterminfantsasamarkerofneonatalintensivecareunitquality
AT puttmary assessmentofsurfactantuseinpreterminfantsasamarkerofneonatalintensivecareunitquality
AT silberjeffreyh assessmentofsurfactantuseinpreterminfantsasamarkerofneonatalintensivecareunitquality